Kevzara Fails COVID-19 Patients for the Last Time
Sanofi and Regeneron reported a phase 3 failure with their rheumatoid arthritis treatment and severely affected COVID-19 patients.
Kevzara Fails COVID-19 Patients for the Last Time
Tweet on Twitter
Share on Facebook
Google+
Pinterest
